113 related articles for article (PubMed ID: 11550164)
1. Impact of hemoglobin levels before and during concurrent chemoradiotherapy on the response of treatment in patients with cervical carcinoma: preliminary results.
Obermair A; Cheuk R; Horwood K; Janda M; Bachtiary B; Schwanzelberger B; Stoiber A; Nicklin JL; Perrin LC; Crandon AJ
Cancer; 2001 Aug; 92(4):903-8. PubMed ID: 11550164
[TBL] [Abstract][Full Text] [Related]
2. Anemia before and during concurrent chemoradiotherapy in patients with cervical carcinoma: Effect on progression-free survival.
Obermair A; Cheuk R; Horwood K; Neudorfer M; Janda M; Giannis G; Nicklin JL; Perrin LC; Crandon AJ
Int J Gynecol Cancer; 2003; 13(5):633-9. PubMed ID: 14675347
[TBL] [Abstract][Full Text] [Related]
3. Impact of hemoglobin on survival of cervical carcinoma patients treated with concurrent chemoradiotherapy is dependent on lymph node metastasis findings by magnetic resonance imaging.
Choi YS; Yi CM; Sin JI; Ye GW; Shin IH; Lee TS
Int J Gynecol Cancer; 2006; 16(5):1846-54. PubMed ID: 17009981
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of hemoglobin level in cervical cancer patients administered definitive radiotherapy.
Serkies K; Badzio A; Jassem J
Acta Oncol; 2006; 45(6):695-701. PubMed ID: 16938812
[TBL] [Abstract][Full Text] [Related]
5. Anemia in patients with locally advanced cervical carcinoma administered preoperative radiochemotherapy: association with pathological response to treatment and clinical outcome.
Ferrandina G; Distefano M; Smaniotto D; Morganti A; Paglia A; Macchia G; Corvari B; Lorusso D; Scambia G
Gynecol Oncol; 2006 Nov; 103(2):500-5. PubMed ID: 16677692
[TBL] [Abstract][Full Text] [Related]
6. Hemoglobin level in cervical cancer: a surrogate for an infiltrative phenotype.
Barkati M; Fortin I; Mileshkin L; Bernshaw D; Carrier JF; Narayan K
Int J Gynecol Cancer; 2013 May; 23(4):724-9. PubMed ID: 23446376
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment serum hemoglobin level as a predictive factor of response to neoadjuvant chemotherapy in patients with locally advanced squamous cervical carcinoma: a preliminary report.
Fuso L; Mazzola S; Marocco F; Ferrero A; Dompè D; Carus AP; Zola P
Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S187-91. PubMed ID: 16185756
[TBL] [Abstract][Full Text] [Related]
8. Chemoradiation of unresectable pancreatic carcinoma: impact of pretreatment hemoglobin level on patterns of failure.
Morganti AG; Forni F; Macchia G; Valentini V; Smaniotto D; Trodella L; Balducci M; Cellini N
Strahlenther Onkol; 2003 Feb; 179(2):87-92. PubMed ID: 12590318
[TBL] [Abstract][Full Text] [Related]
9. [Anemia impact on treatments of cervical carcinomas].
Marchal C; Rangeard L; Brunaud C
Cancer Radiother; 2005 Mar; 9(2):87-95. PubMed ID: 15820436
[TBL] [Abstract][Full Text] [Related]
10. The effect of hemoglobin level on radiotherapy outcomes: the Canadian experience.
Thomas G
Semin Oncol; 2001 Apr; 28(2 Suppl 8):60-5. PubMed ID: 11395855
[TBL] [Abstract][Full Text] [Related]
11. Severity, risk factors, and physician practices in the management of anemia during concurrent chemoradiation for head and neck carcinoma.
Tanvetyanon T; Choudhury AM
Cancer; 2006 Apr; 106(7):1554-9. PubMed ID: 16518817
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Effects of Hemoglobin Levels Upon Tumor Response among Cervical Carcinoma Patients Undergoing Accelerated Hyperfractionated Radiotherapy versus Cisplatin Chemoradiotherapy.
Thakur P; Seam RK; Gupta MK; Rastogi M; Gupta M; Bhattacharyya T; Sharma M; Revannasiddaiah S
Asian Pac J Cancer Prev; 2015; 16(10):4285-9. PubMed ID: 26028087
[TBL] [Abstract][Full Text] [Related]
13. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix.
Grogan M; Thomas GM; Melamed I; Wong FL; Pearcey RG; Joseph PK; Portelance L; Crook J; Jones KD
Cancer; 1999 Oct; 86(8):1528-36. PubMed ID: 10526282
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of hemoglobin levels on treatment outcome in patients with nasopharyngeal carcinoma treated with sequential chemoradiotherapy or radiotherapy alone.
Chua DT; Sham JS; Choy DT
Cancer; 2004 Jul; 101(2):307-16. PubMed ID: 15241828
[TBL] [Abstract][Full Text] [Related]
15. Association of hemoglobin level with survival in cervical carcinoma patients treated with concurrent cisplatin and radiotherapy: a Gynecologic Oncology Group Study.
Winter WE; Maxwell GL; Tian C; Sobel E; Rose GS; Thomas G; Carlson JW
Gynecol Oncol; 2004 Aug; 94(2):495-501. PubMed ID: 15297194
[TBL] [Abstract][Full Text] [Related]
16. Improvement in performance status after erythropoietin treatment in lung cancer patients undergoing concurrent chemoradiotherapy.
Casas F; Viñolas N; Ferrer F; Farrús B; Gimferrer JM; Agustí C; Belda J; Luburich P
Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):116-24. PubMed ID: 12504043
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the prognostic impact of tumor embolization before definitive radiotherapy for cervical carcinoma.
Kapp KS; Poschauko J; Tauss J; Berghold A; Oechs A; Lahousen M; Petru E; Winter R; Kapp DS
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1399-404. PubMed ID: 16029799
[TBL] [Abstract][Full Text] [Related]
18. Effects of anemia correction with epoetin beta in patients receiving radiochemotherapy for advanced cervical cancer.
Strauss HG; Haensgen G; Dunst J; Hayward CR; Burger HU; Scherhag A; Koelbl H
Int J Gynecol Cancer; 2008; 18(3):515-24. PubMed ID: 17645506
[TBL] [Abstract][Full Text] [Related]
19. Relationship between low hemoglobin levels and outcomes after treatment with radiation or chemoradiation in patients with cervical cancer: has the impact of anemia been overstated?
Bishop AJ; Allen PK; Klopp AH; Meyer LA; Eifel PJ
Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):196-205. PubMed ID: 25446609
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of hemoglobin levels prior to radiotherapy for cervical cancer--Kuwait experience.
Abuzallouf S; Vasishta S; Ragheb A; Varghese A; El-Hattab O
Gulf J Oncolog; 2008 Jan; (3):41-5. PubMed ID: 20084796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
